As I mentioned earlier, when we began this process in 2017, we already owned 85% of the intellectual property developed on the Telus Health Exchange platform. That platform was intended to offer many more services than just e-prescribing, such as e-consultation or e-prescribing services, among other things. For us, this is therefore a significant asset that will be used in the future to provide other services to citizens.
